Is linezolid safe during breastfeeding?

Linezolid Safety in Breastfeeding

Linezolid should be used with caution during breastfeeding and is generally not recommended as a first-line option due to limited human safety data and potential infant toxicity concerns.

Evidence from FDA Drug Labeling

The FDA label for linezolid explicitly states that linezolid and its metabolites are excreted in the milk of lactating rats at concentrations similar to maternal plasma 1. Critically, it is not known whether linezolid is excreted in human milk, and the label recommends that caution should be exercised when administering linezolid to a nursing woman 1.

Human Data on Breast Milk Transfer

The most relevant human data comes from a case report showing that linezolid does transfer into breast milk with a relative infant dose of 15.61% at steady state 2. This is concerning because:

• The relative infant dose exceeds the generally accepted safety threshold of 10% for most medications
• The estimated infant dose would be 1.84 mg/kg/day, which is below the neonatal therapeutic dose but still represents significant exposure 2
• In this case, the infant did not actually breastfeed during maternal treatment 2

Safety Concerns for the Infant

Animal studies demonstrate serious toxicity concerns that should inform clinical decision-making:

• In rat studies, when lactating dams received linezolid, all dams and offspring died within 4 days at therapeutic doses 3
• Even at 1/4 therapeutic dose, linezolid caused significant oxidative stress, liver damage with DNA fragmentation, and kidney deterioration in nursing pups 3
• Pup body weight was significantly reduced 3

Clinical Context and Alternatives

While one review suggested linezolid "appears to be relatively safe in the minimal quantities nursing infants ingest" 4, this was based on limited data and theoretical considerations rather than robust clinical evidence. The review acknowledged that information for linezolid was limited and emphasized the need for close monitoring of breastfed infants 4.

Practical Recommendations

If linezolid must be used during breastfeeding:

1. Consider alternative antibiotics first - Many other antibiotics have better-established safety profiles during lactation (e.g., vancomycin, amoxicillin) 5

2. If no alternatives exist and linezolid is essential:

   • Discuss risks and benefits thoroughly with the mother
   • Consider temporary cessation of breastfeeding during treatment
   • If breastfeeding continues, monitor the infant closely for:
     • Signs of bone marrow suppression (pallor, bruising, infections)
     • Gastrointestinal disturbances
     • Poor feeding or lethargy
     • Any signs of toxicity

3. Duration matters - Linezolid is associated with cumulative toxicity, particularly hematological effects 6, 7. Shorter courses may be safer if breastfeeding continues.

4. Therapeutic drug monitoring - Given the high relative infant dose and individual variability, therapeutic drug monitoring in the mother may help minimize infant exposure while maintaining efficacy 7

Important Caveats

• The 15.61% relative infant dose substantially exceeds the 10% safety threshold used for most medications during lactation 2
• Unlike antibiotics with extensive lactation safety data (ciprofloxacin, amoxicillin, vancomycin), linezolid lacks adequate human safety studies 5
• The severe toxicity observed in animal lactation studies, including mortality at therapeutic doses, raises significant concerns 3

In summary, while linezolid may be used during breastfeeding when absolutely necessary and no safer alternatives exist, it should not be considered a preferred option, and temporary cessation of breastfeeding should be strongly considered during treatment.